Combination Therapy For B Cell Disorders

Patent No. EP1631313 (titled "Combination Therapy For B Cell Disorders") was filed by Genentech on Jun 4, 2004. The application was issued on Mar 11, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GLAXOSMITHKLINE INTELLECTUAL MANAGEMENTDec 4, 2015HITCHCOCK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1631313

GENENTECH
Application Number
EP04754321A
Filing Date
Jun 4, 2004
Status
Revoked
Oct 5, 2021
Publication Date
Mar 11, 2015